MAPK1 and COVID-19: In order to effectively reduce the inhibition of COVID-19 on spermatogenesis, we hope to find drugs that can effectively inhibit the negative effect of MAPK pathway in COVID-19 infected patients, especially for MAPK1 and MAPK14.